We are live on ! Find out more
RPTX

Repare Therapeutics
RPTX

Delisted

RPTX was delisted on the 27th of January, 2026.

Back to rankings

76 hedge funds and large institutions have $438M invested in Repare Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,522% more call options, than puts

Call options by funds: $13M | Put options by funds: $803K

15% more capital invested

Capital invested by funds: $379M → $438M (+$58.6M)

1.03% more ownership

Funds ownership: 85.1% → 86.13% (+1%)

10% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

3% less funds holding

Funds holding: 78 → 76 (-2)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
76
Holders Change
-2
Holders Change %
-2.56%
% of All Funds
1.21%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
9
Increased
23
Reduced
21
Closed
10
Calls
$13M
Puts
$803K
Net Calls
+$12.2M
Net Calls Change
+$12.3M

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$3.51M
2
LGM
Logos Global Management
California
+$3.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.26M
4
CM
Caption Management
Oklahoma
+$899K
5
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$758K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.1M
2
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$1.1M
3
Citadel Advisors
Citadel Advisors
Florida
-$988K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$914K
5
CS
Candriam SCA
Luxembourg
-$529K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
26
Vanguard Group
Pennsylvania
$907K +$5.16K +500 +0.7%
Goldman Sachs
27
Goldman Sachs
New York
$777K -$6.93K -671 -1%
State Street
28
State Street
Massachusetts
$652K +$4.52K +438 +0.8%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$619K -$37.2K -3,607 -7%
Morgan Stanley
30
Morgan Stanley
New York
$608K +$10.5K +1,018 +2%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$569K +$486K +47,087 New
HCA
32
Harbor Capital Advisors
Illinois
$508K +$52.6K +5,101 +14%
Swiss National Bank
33
Swiss National Bank
Switzerland
$492K – – –
AG
34
Algert Global
California
$371K – – –
TI
35
Trexquant Investment
Connecticut
$356K -$273K -26,476 -47%
CS
36
Credit Suisse
Switzerland
$326K -$9.82K -951 -3%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$321K -$55.2K -5,347 -17%
Blackstone Inc
38
Blackstone Inc
New York
$314K +$34.7K +3,362 +15%
GCP
39
GSA Capital Partners
United Kingdom
$280K +$239K +23,141 New
HF
40
HRT Financial
New York
$275K +$87.7K +8,499 +59%
TD Asset Management
41
TD Asset Management
Ontario, Canada
$275K – – –
Millennium Management
42
Millennium Management
New York
$274K -$1.1M -106,461 -82%
Simplex Trading
43
Simplex Trading
Illinois
$233K +$141K +13,621 +240%
Squarepoint
44
Squarepoint
New York
$220K +$188K +18,180 New
American Century Companies
45
American Century Companies
Missouri
$216K +$53.4K +5,174 +41%
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
$206K – – –
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$202K +$857 +83 +0.5%
Connor, Clark & Lunn Investment Management (CC&L)
48
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$180K +$36.1K +3,493 +31%
Northern Trust
49
Northern Trust
Illinois
$178K -$76.8K -7,439 -34%
CLOS
50
Compagnie Lombard Odier SCmA
Switzerland
$169K – – –
1
2
3 4

RPTX Hedge Fund Activity: Q3 2023 in Review

76 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q3 2023, worth a combined $438M — up 15% from $379M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RPTX and 9 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 23 added.

The largest buyer was Deep Track Capital, adding an estimated $3.51M. The largest seller was Millennium Management, cutting an estimated $1.1M.

  • 76 institutional investors held Repare Therapeutics (RPTX) as of Q3 2023, down from 78 in Q2 2023.
  • Funds reported $438M of Repare Therapeutics stock for Q3 2023, up 15% quarter-over-quarter.
  • 9 funds opened new Repare Therapeutics positions in Q3 2023 and 10 closed out, a net change of -1 holder.
  • The largest Repare Therapeutics buyer in Q3 2023 was Deep Track Capital, an estimated $3.51M added.
  • The largest Repare Therapeutics seller in Q3 2023 was Millennium Management, an estimated $1.1M sold.

Based on aggregated 13F filings for Q3 2023.